Literature DB >> 27596926

Recent developments in the pharmacology of prenylated xanthones.

Salvatore Genovese1, Serena Fiorito1, Vito Alessandro Taddeo1, Francesco Epifano2.   

Abstract

Prenylated xanthones are secondary metabolites that are particularly common in plants belonging to the Clusiaceae family. Such compounds have been the focus intensive research because of their potential as biologically active agents. Here, we survey data published over the past decade relating to the properties of prenylated xanthones to provide a more detailed view of the potential of these naturally occurring compounds as therapeutic agents.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27596926     DOI: 10.1016/j.drudis.2016.06.033

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  3 in total

1.  New depsidone and dichromone from the stems of Garcinia paucinervis with antiproliferative activity.

Authors:  CuiCui Jia; JingJing Xue; XinYu Li; DaHong Li; ZhanLin Li; HuiMing Hua
Journal:  J Nat Med       Date:  2018-09-04       Impact factor: 2.343

2.  α-Mangostin reduced the viability of A594 cells in vitro by provoking ROS production through downregulation of NAMPT/NAD.

Authors:  Yan-Yun Ding; Jia-Jie Luan; Yan Fan; Opeyemi Joshua Olatunji; Jing Song; Jian Zuo
Journal:  Cell Stress Chaperones       Date:  2020-01-02       Impact factor: 3.667

3.  Enantiomeric Resolution and Docking Studies of Chiral Xanthonic Derivatives on Chirobiotic Columns.

Authors:  Ye' Zaw Phyo; Sara Cravo; Andreia Palmeira; Maria Elizabeth Tiritan; Anake Kijjoa; Madalena M M Pinto; Carla Fernandes
Journal:  Molecules       Date:  2018-01-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.